BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

NCT04982393 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
207
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Alnylam Pharmaceuticals